Analysts’ downgrades for Monday, November 2nd:
Acumen Pharmaceuticals (NASDAQ:ABOS) was downgraded by analysts at Bank of America from a buy rating to an underperform rating. Bank of America currently has $1.00 target price on the stock.
Autodesk (NASDAQ:ADSK) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.
Arthur J. Gallagher & Co. (NYSE:AJG) was downgraded by analysts at Citigroup from a buy rating to a neutral rating. The firm currently has $300.00 price target on the stock, up from their previous price target of $285.00.
Alnylam Pharmaceuticals (NASDAQ:ALNY) was downgraded by analysts at Truist Financial from a buy rating to a hold rating. The firm currently has $225.00 price target on the stock, down from their previous price target of $315.00.
Bausch + Lomb (NYSE:BLCO) was downgraded by analysts at HC Wainwright from a buy rating to a neutral rating. HC Wainwright currently has $22.00 target price on the stock, up from their previous target price of $21.00.
Cullen/Frost Bankers (NYSE:CFR) was downgraded by analysts at Keefe, Bruyette & Woods from an outperform rating to a market perform rating. The firm currently has $175.00 price target on the stock, down from their previous price target of $180.00.
Cummins (NYSE:CMI) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.
Franklin Electric (NASDAQ:FELE) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.
Hilton Grand Vacations (NYSE:HGV) was downgraded by analysts at Citizens Jmp from a market outperform rating to a market perform rating.
Karyopharm Therapeutics (NASDAQ:KPTI) was downgraded by analysts at Rodman & Renshaw from a buy rating to a neutral rating.
Cheniere Energy (NYSE:LNG) was downgraded by analysts at Wolfe Research from an outperform rating to a peer perform rating.
MidCap Financial Investment (NASDAQ:MFIC) was downgraded by analysts at Truist Financial from a buy rating to a hold rating. They currently have $11.00 target price on the stock, down from their previous target price of $12.00.
NeuroSense Therapeutics (NASDAQ:NRSN) was downgraded by analysts at HC Wainwright from a buy rating to a neutral rating.
Perion Network (NASDAQ:PERI) was downgraded by analysts at Craig Hallum from a buy rating to a hold rating. Craig Hallum currently has $11.70 target price on the stock.
PennyMac Financial Services (NYSE:PFSI) was downgraded by analysts at Keefe, Bruyette & Woods from an outperform rating to a market perform rating. The firm currently has $80.00 target price on the stock, down from their previous target price of $100.00.
Qualys (NASDAQ:QLYS) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.
Reddit (NYSE:RDDT) was downgraded by analysts at Evercore from an outperform rating to an in-line rating. Evercore currently has $120.00 price target on the stock.
Reddit (NYSE:RDDT) was downgraded by analysts at Loop Capital from a buy rating to a hold rating. They currently have $100.00 target price on the stock.
ResMed (NYSE:RMD) was downgraded by analysts at Canaccord Genuity Group from a buy rating to a hold rating.
Rush Street Interactive (NYSE:RSI) was downgraded by analysts at Craig Hallum from a buy rating to a hold rating. Craig Hallum currently has $15.00 price target on the stock.
Sandisk (NASDAQ:SNDK) was downgraded by analysts at Fox Advisors from an overweight rating to an equal weight rating.
Teladoc Health (NYSE:TDOC) was downgraded by analysts at Argus from a hold rating to a sell rating.
TE Connectivity (NYSE:TEL) was downgraded by analysts at Fox Advisors from an overweight rating to an equal weight rating.
Receive News & Ratings for Acumen Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acumen Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.
